SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioSpecifics Technologies Corporation Announces Online Publication in The Journal of Urology of Results From the IMPRESS Trials of XIAFLEX® in Peyronie's Disease